Nongenomic vascular action of aldosterone in the glomerular microcirculation

Journal of the American Society of Nephrology

Volumn 14, Issue 9, 2003, Pages 2255-2263

  Arima, Shuji ^a   Kohagura, Kentaro ^a   Xu, Hong Lan ^a   Sugawara, Akira ^a   Abe, Takaaki ^a   Satoh, Fumitoshi ^a   Takeuchi, Kazuhisa ^a   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; EFONIDIPINE; NEOMYCIN; NIFEDIPINE; PHOSPHOLIPASE C; SPIRONOLACTONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTICLE; CALCIUM MOBILIZATION; CAPILLARY PRESSURE; CHANNEL GATING; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; ENZYME ACTIVATION; GLOMERULOSCLEROSIS; GLOMERULUS; HORMONE ACTION; HYPERTENSION; KIDNEY CIRCULATION; KIDNEY DISEASE; KIDNEY VASCULAR RESISTANCE; MALE; MALIGNANT HYPERTENSION; MEMBRANE PERMEABILITY; MICROCIRCULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA; RABBIT; VASCULARIZATION; VASOCONSTRICTION;

EID: 0041318968     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000083982.74108.54     Document Type: Article

References (43)

1. Anderson S, Rennke H, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal diseases associated with systemic hypertension in the rat. J Clin Invest 77: 1993-2000, 1986
2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
3. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45: 403-410, 1994
4. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 51: 2-15, 1997
5. Ibrahim HN, Rosenberg ME, Hostetter TH: Role of renin-angiotensin-aldosterone system in the progression of renal disease: A critical review. Semin Nephrol 17: 431-440, 1997
6. Quan ZY, Walser M, Hill GS: Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level. Kidney Int 41: 326-333, 1992
7. Greene E, Kren S, Hostetter TH: Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98: 1063-1068, 1996
8. Rocha R, Chander PN, Zuckerman A, Stier CT: Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 33: 232-237, 1999
9. Hostetter TH, Rosenberg ME, Ibrahim HN, Juknevicius I: Aldosterone in renal disease. Curr Opin Nephrol Hypertens 10: 105-110, 2001
10. Epstein M: Aldosterone as a mediator of progressive renal disease: Pathogenic and clinical implications. Am J Kidney Dis 37: 677-688, 2001
11. Rocha R, Stier CT Jr, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH, Adler GK: Aldosterone: A mediator of myocardial necrosis and renal arteriopathy. Endocrinology 141: 3871-3878, 2000
12. Ito S, Johnson CS, Carretero OA: Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 87: 1656-1663, 1991
13. Ito S, Arima S, Ren Y, Juncos LA, Carretero OA: Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 91: 2012-2019, 1993
14. Arima S, Ito S, Omata K, Tsunoda K, Yaoita H, Abe K: Diverse effects of calcium antagonists on the glomerular hemodynamics. Kidney Int 49[Suppl 55]: S132-S134, 1996
15. Christ M, Gunther A, Heck M, Schmidt BMW, Falkenstein E, Wehling M: Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells. Circulation 99: 1485-1491, 1999
16. Schafer C, Shahin V, Albermann L, Hug MJ, Reinhardt J, Schillers H, Schneider SW, Oberleithner H: Aldosterone signaling pathway across the nuclear envelope. Proc Natl Acad Sci U S A 99: 7154-7159, 2002
17. Browne M, Connolly C, Dicherty JR: Vascular actions of 17b-oestradiol in rat aorta and mesenteric artery. J Auton Pharmacol 19: 291-299, 1999
18. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M: Multiple actions of steroid hormones - A focus on rapid, nongenomic effects. Pharmacol Rev 52: 513-555, 2000
19. Wehling M, Neylon CB, Fullerton M, Bobik A, Funder JW: Nongenomic effects of aldosterone on intracellular calcium in vascular smooth muscle cells. Circ Res 76: 973-979, 1995
20. Christ M, Douwes K, Eisen C, Bechtner G, Theisen K, Wehling M: Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells. Hypertension 26: 117-123, 1995
21. Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T: Disparate effects of calcium antagonists on renal microcirculation. Hypertens Res 19: 31-36, 1996
22. Arima S, Ito S, Omata K, Tsunoda K, Yaoita H, Abe K: Diverse hemodynamic effects of calcium blockade in renal microcirculation [Abstract]. J Hypertens 14[Suppl 1]:S45, 1996
23. Dworkin LD, Hostetter TH, Rennke HG, Brenner BM: Hemodynamic basis for glomerular injury in rats with deoxycorticosterone-salt hypertension. J Clin Invest 73: 1448-1461, 1984
24. Al-Dujaili EAS, Edwards CRW: The development and application of direct radioimmunoassay for plasma aldosterone using 131-I-labelled ligand-comparison of three methods. J Clin Endocrinol Metab 46: 105-113, 1978
25. + pump. Circ Res 86: 37-42, 2000
26. Berl T, Katz FH, Henrich WL, de Torrente A, Schrier RW: Role of aldosterone in the control of sodium excretion in patients with advanced chronic renal failure. Kidney Int 14: 228-235, 1978
27. Hene RJ, Boer P, Koomans HA, Mees EJD: Plasma aldosterone concentrations in chronic renal disease. Kidney Int 21: 98-101, 1982
28. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375-380, 1982
29. Zats R, Dunn R, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930, 1986
30. Neuringer JR, Brenner BM: Hemodynamic theory of progressive renal disease: A 10-year update in brief review. Am J Kidney Dis 22: 98-104, 1993
31. Horiuchi M, Nishiyama H, Hama J, Takenaka T, Hondo H, Kino H, Nagata S, Sugimura K, Katori R: Characterization of renal aldosterone receptors in gebnetically hypertensive rats. Am J Physiol 264: F286-F291, 1993
32. Imig JD, falck JR, Gebremedhin D, Harder DR, Roman RJ: Elevated renovascular tone in young spontaneously hypertensive rats: Role of cytochrome P-450. Hypertension 22: 357-364, 1993
33. Funder JW: Aldosterone action: Fact failure and the future. Clin Expt Pharmacol Physiol 25: S47-S50, 1998
34. Wehling M, Spes CH, Win N, Anson CP, Schmidt BMW, Theisen SK, Christ M: Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 83: 3517-3522, 1998
35. Schmidt BMW, Montealegre A, Janson CP, Martin N, Stein-Kemmesies C, Scherhag A, Feuring M, Christ M, Wehling M: Short term cardiovascular effects of aldosterone in healthy male volunteers. J Clin Endocrinol Metab 84: 3528-3533, 1999
36. Wehling M, Christ M, Theisen K: Membrane receptors for aldosterone: A novel pathway for mineralocorticoid action. Am J Physiol 263: E974-E979, 1992
37. Christ M, Sippel K, Eisen C, Wehling M: Non-classical receptors for aldosterone in plasma membranes from pig kidneys. Mol Cell Endocrinol 99: R31-R34, 1994
38. Kamm KE, Stull JT: Regulation of smooth muscle contractile elements by second messengers. Annu Rev Physiol 51: 299-313, 1989
39. Christ M, Meyer C, Sippel K, Wehling M: Rapid aldosterone signaling in vascular smooth muscle cells: Involvement of phospholipase C, diacylglycerol and protein kinase C. Biochem Biophys Res Commun 213: 123-129, 1995
40. Nagahama T, Hayashi K, Ozawa Y, Takenaka T, Saruta T: Role of protein kinase C in angiotensin II-induced constriction of renal microvessels. Kidney Int 57: 215-223, 2000
41. Rocha R, Chander PN, Khanna K, Zuckerman A, Stier CT Jr: Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 31: 451-458, 1998
42. Lim-Tio SS, Fuller PJ: Intracellular signaling pathways confer specificity of transactivation by mineralocorticoid and glucocorticoid receptors. Endocrinology 139: 1653-1661, 1998
43. Romagni P, Rossi F, Guerrini L, Quirini C, Santiemma V: Aldosterone induces contraction of the resistance arteries in man. Atherosclerosis 166: 345-349, 2003